• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem Myocardial Infarction (1969)
Event Date 03/05/2022
Event Type  Injury  
Event Description
Agent ide study: it was reported that in-stent restenosis occurred.On (b)(6)2012, four promus stents were implanted in the right coronary artery (rca).On (b)(6) 2021, during the index procedure to treat the left circumflex artery (lcx) a promus premier stent was also implanted in the rca.On (b)(6) 2022, the subject presented emergently with complaints of worsening substernal pressure like chest pain, radiating to left neck and jaw.Sublingual nitroglycerin was given, that mildly decreased the chest pain from 8/10 to 2/10, along with imdur, which was ongoing at the time of admission.On examination, the subject was having shortness of breath, nausea, diaphoresis and mild epigastric discomfort.The subject was hospitalized on the same day for further evaluation and treatment.The subject was diagnosed with chest pain with acute coronary syndrome and acute inferior st elevation myocardial infarction.The subject was on clopidogrel at the time of the event.Diagnostic coronary angiography revealed 60% stenosis at distal segment of the previously placed promus drug eluting stents implanted in the rca.The 99% in-stent restenosis in the proximal to distal lcx was treated with percutaneous coronary intervention.The event was considered recovered/resolved and the subject was discharged on clopidogrel.On (b)(6) 2022, the subject presented emergently with worsening chest pain, which was not relieved by nitroglycerin.It was reported that the subject had experienced palpitation episodes at home with heart rate ranging from 40-186.The subject was hospitalized on the same day for further evaluation and treatment.The subject was diagnosed with severe in-stent restenosis involving the mid to distal large lcx.The subject was diagnosed with myocardial infarction and revascularization was recommended.On examination, the subject was having chest pain, occasional diaphoresis and shortness of breath.Medication was changed from eliquis to lovenox for paroxysmal atrial fibrillation.On (b)(6) 2022, diagnostic coronary angiography revealed 15% stenosis at the ostial to distal segment of the previously placed promus stents implanted in the rca and 100% stenosis at the rpda.Restenosis in the distal lcx was treated with percutaneous coronary intervention.The event was considered resolved with sequelae and the subject was discharged on eliquis and brilinta.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
IC  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16292684
MDR Text Key308734508
Report Number2124215-2023-04240
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age74 YR
Patient SexFemale
Patient RaceWhite
-
-